Phenotypic Exploration of Autism Spectrum Disorders Retrospective and Prospective Data

Recruiting now

Conditions studied: Autism Spectrum Disorder

In brief

Autism Spectrum Disorders (ASD) are a heterogeneous group of severe developmental abnormalities of the nervous system characterized by deficits in social interaction and verbal and nonverbal communication affecting approximately 1% of the general population. In 5-40% of cases, genetic factors are identified as the cause of these disorders. Despite this unique definition and the advancement of techniques, ASD is still a clinically and genetically heterogeneous condition, as several hundred genes have been identified to date. Primary Objective and Endpoint Primary Objective: Exploration of phenotypic heterogeneity in patients with ASD. Primary endpoint: * Routine Care Clinical Investigation Criteria. * Scores on assessment scales,

Key facts

Study ID

NCT04923854

Run by

Assistance Publique - Hôpitaux de Paris

People needed

1500

Starts

2021-07-01

Expected to finish

2027-07-01

Last updated by the study team

2022-04-18

Who can join

Age: 1 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• child (age <18 years) with Autism Spectrum DisorderAutism Spectrum Disorder

Where it is running

• Hôpital Robert Debré — Paris, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.